Cargando…

The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients

BACKGROUND: Sepsis causes high mortality in vulnerable groups such as hematologic malignancy (HM) patients. There are various early warning scores of sepsis, eg, qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS). This study aimed to compare REWS, qSOFA, and SOFA in predicting severe complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sricharoen, Pungkava, Chueluecha, Chaithawat, Yuksen, Chaiyaporn, Jenpanitpong, Chetsadakon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827160/
https://www.ncbi.nlm.nih.gov/pubmed/35153518
http://dx.doi.org/10.2147/OAEM.S345308
_version_ 1784647570447925248
author Sricharoen, Pungkava
Chueluecha, Chaithawat
Yuksen, Chaiyaporn
Jenpanitpong, Chetsadakon
author_facet Sricharoen, Pungkava
Chueluecha, Chaithawat
Yuksen, Chaiyaporn
Jenpanitpong, Chetsadakon
author_sort Sricharoen, Pungkava
collection PubMed
description BACKGROUND: Sepsis causes high mortality in vulnerable groups such as hematologic malignancy (HM) patients. There are various early warning scores of sepsis, eg, qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS). This study aimed to compare REWS, qSOFA, and SOFA in predicting severe complications in hematologic malignancy patients visiting ED. METHODS: The study was conducted as a retrospective cohort study at the ED of Ramathibodi Hospital, Bangkok, Thailand. Adult HM patients suspected of sepsis and have visited ED between March 2016 and December 2019. RESULTS: Among 124 patients in our cohort, 51 (41%) had serious complication in ED and 20 (16%) died within 28 days after admission. The AUROCs of SOFA and qSOFA indicate significantly higher predicting in serious complication in ED than REWS (SOFA, 0.81 [95% CI, 0.73–0.89], qSOFA, 0.73 [95% CI, 0.65–0.81], REWS, 0.62 [95% CI, 0.52–0.72] p=0.004) while the predicting in 28-day mortality is not statistically significantly different (SOFA, 0.73 [95% CI, 0.60–0.85], qSOFA, 0.69 [95% CI, 0.58–0.80], REWS, 0.60 [95% CI, 0.44–0.75] p=0.25). CONCLUSION: The SOFA score is highest in predicting severe complications among hematologic malignancy patients.
format Online
Article
Text
id pubmed-8827160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-88271602022-02-11 The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients Sricharoen, Pungkava Chueluecha, Chaithawat Yuksen, Chaiyaporn Jenpanitpong, Chetsadakon Open Access Emerg Med Original Research BACKGROUND: Sepsis causes high mortality in vulnerable groups such as hematologic malignancy (HM) patients. There are various early warning scores of sepsis, eg, qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS). This study aimed to compare REWS, qSOFA, and SOFA in predicting severe complications in hematologic malignancy patients visiting ED. METHODS: The study was conducted as a retrospective cohort study at the ED of Ramathibodi Hospital, Bangkok, Thailand. Adult HM patients suspected of sepsis and have visited ED between March 2016 and December 2019. RESULTS: Among 124 patients in our cohort, 51 (41%) had serious complication in ED and 20 (16%) died within 28 days after admission. The AUROCs of SOFA and qSOFA indicate significantly higher predicting in serious complication in ED than REWS (SOFA, 0.81 [95% CI, 0.73–0.89], qSOFA, 0.73 [95% CI, 0.65–0.81], REWS, 0.62 [95% CI, 0.52–0.72] p=0.004) while the predicting in 28-day mortality is not statistically significantly different (SOFA, 0.73 [95% CI, 0.60–0.85], qSOFA, 0.69 [95% CI, 0.58–0.80], REWS, 0.60 [95% CI, 0.44–0.75] p=0.25). CONCLUSION: The SOFA score is highest in predicting severe complications among hematologic malignancy patients. Dove 2022-02-05 /pmc/articles/PMC8827160/ /pubmed/35153518 http://dx.doi.org/10.2147/OAEM.S345308 Text en © 2022 Sricharoen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sricharoen, Pungkava
Chueluecha, Chaithawat
Yuksen, Chaiyaporn
Jenpanitpong, Chetsadakon
The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
title The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
title_full The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
title_fullStr The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
title_full_unstemmed The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
title_short The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
title_sort use of qsofa, sofa, and ramathibodi early warning score (rews) to predict severe complications in hematologic malignancy patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827160/
https://www.ncbi.nlm.nih.gov/pubmed/35153518
http://dx.doi.org/10.2147/OAEM.S345308
work_keys_str_mv AT sricharoenpungkava theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients
AT chueluechachaithawat theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients
AT yuksenchaiyaporn theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients
AT jenpanitpongchetsadakon theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients
AT sricharoenpungkava useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients
AT chueluechachaithawat useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients
AT yuksenchaiyaporn useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients
AT jenpanitpongchetsadakon useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients